Today, the Advisory Committee on Immunization Practices (ACIP) voted to end its recommendation of the universal birth dose of the Hepatitis B (HepB) vaccine and instead recommend the birth dose only f ...

This section provides key information on oncology events organized by ASCO or other organizations throughout the world. To submit an event, please fill out this form. Content on ASCO's Calendar of ...

*During data validation and verification for the manuscript, one patient that was originally reported as having a response in the 2021 AACR Annual Meeting presentation of this cohort was found instead ...

Best of ASCO® delivers the essential highlights from the ASCO Annual Meeting, so you can stay current on the latest advances in oncology.

Access the best of the ASCO Annual Meeting in a city near you. The Best of ASCO® Licensed Programs provide a curated review of the year’s most significant scientific findings. Browse all available ...

Access the best of the ASCO Annual Meeting in a city near you. The Best of ASCO® Licensed Programs provide a curated review of the most impactful, practice-hanging research presented at the ASCO ...

The Career Development Award (CDA) provides research funding to clinical investigators, who have received their initial faculty appointment, as they work to establish an independent clinical cancer ...

ASCO stands with our Ukrainian members, the worldwide oncology community, and health care providers around the globe in condemning Russia’s unprovoked war on Ukraine. We call for an immediate ...

The ASCO Nominating Committee has selected 13 distinguished members as candidates for open leadership positions within the Society. ASCO encourages all eligible members to cast their ballots to choose ...

Robin T. Zon, Erin B. Kennedy, Kerin Adelson, Sibel Blau, Natalie Dickson, David Gill, Nicole Laferriere, Ana Maria Lopez, Therese M. Mulvey, Debra Patt, Todd A ...

The American Society of Clinical Oncology (ASCO) today released a position statement on state drug repository programs, outlining ASCO’s support for drug repository programs solely for oral ...

ASCO has been notified about a recent safety update relating to the drug COPIKTRA TM (duvelisib) under the Food and Drug Administration’s (FDA) Risk Evaluation and Mitigation Strategy (REMS) program.